| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology, Division of Neuroscience, University of Alberta, Edmonton, Alberta T6G 2S2, Canada
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
FOOTNOTES
REFERENCES
ABSTRACT 
Allan, Douglas W., and John J. Greer. Pathogenesis of
nitrofen-induced congenital diaphragmatic hernia in fetal rats. J. Appl. Physiol. 83(2): 338-347, 1997.
Congenital diaphragmatic hernia (CDH) is a developmental anomaly
characterized by the malformation of the diaphragm and impaired lung
development. In the present study, we tested several hypotheses
regarding the pathogenesis of CDH, including those suggesting that the
primary defect is due to abnormal 1)
lung development, 2) phrenic nerve
formation, 3) developmental
processes underlying diaphragmatic myotube formation, 4) pleuroperitoneal canal closure,
or 5) formation of the primordial diaphragm within the pleuroperitoneal fold. The
2,4-dichloro-phenyl-p-nitrophenyl ether (nitrofen)-induced CDH rat model was used for this
study. The following parameters were compared between normal and
herniated fetal rats at various stages of development:
1) weight, protein, and DNA content
of lungs; 2) phrenic nerve diameter,
axonal number, and motoneuron distribution;
3) formation of the phrenic nerve intramuscular branching pattern and diaphragmatic myotube formation; and 4) formation of the precursor of
the diaphragmatic musculature, the pleuroperitoneal fold. We
demonstrated that previously proposed theories regarding the primary
role of the lung, phrenic nerve, myotube formation, and the closure of
pleuroperitoneal canal in the pathogenesis of CDH are incorrect.
Rather, the primary defect associated with CDH, at least in the
nitrofen rat model, occurs at the earliest stage of diaphragm
development, the formation of the pleuroperitoneal fold.
breathing; lung; phrenic
INTRODUCTION CONGENITAL DIAPHRAGMATIC HERNIA (CDH) is a
developmental anomaly characterized by the malformation of the
diaphragm. Normally, during in utero development, the diaphragm
develops to form a continuous sheet that completely separates the
thoracic and abdominal cavities. However, in the instance of CDH,
regions of the diaphragm are missing. Consequently, the developing
viscera have access through an opening in the diaphragm to the thoracic
cavity, which they invade, occupying space normally reserved to
accommodate the growing lungs. As a result, newborns with CDH
(~1:3,000 births) suffer from a combination of pulmonary hypoplasia,
pulmonary hypertension, and surfactant deficiency (19, 28). The
mortality rate of infants suffering from CDH is ~50% (17). Moreover,
it has been estimated that an additional 1 in 2,000 conceptions fails
to reach term because of complications associated with CDH
(15).
Although the mechanisms underlying the etiology of CDH remain obscure,
there are a number of theories pertaining to the pathogenesis of the
condition. First, a persistent theory states that the diaphragmatic malformation is merely a secondary defect caused by the maldevelopment of the adjacent lung tissue (18). Second, Iritani (18) has suggested
that a perturbation of the normal innervation of the diaphragm by the
phrenic nerve may subsequently arrest proper diaphragmatic muscle
development. A third explanation for CDH, the most commonly cited,
states that there is an abnormality with the closure of the
pleuroperitoneal canal (27). Fourth, it has been suggested
that the developing muscle fibers (myotubes) within the region of
herniation may fail to form or are weak and prone to rupture in the
presence of underlying forces produced by the expanding abdominal
contents (27). However, very little scientific data support any of
these theories, and a basic understanding is lacking of how the normal,
let alone the pathological, diaphragm develops (20, 27). To increase
such an understanding, we have examined the normal ontogenesis of the
phrenic nerve and diaphragm in fetal rats (2) and, in the present
study, we systematically test each of the above-mentioned hypotheses
regarding the pathogenesis of CDH.
We have utilized the
2,4-dichloro-phenyl-p-nitrophenyl
ether (nitrofen)-induced CDH rat model to examine lung growth, phrenic nerve innervation, and the formation of the diaphragmatic musculature in instances of CDH. We determined whether abnormalities in their development were either primary or secondary to herniation of the
diaphragm. Nitrofen is a toxic herbicide that, when given as a single
oral dose to a pregnant rat, produces a condition in fetal rats
remarkably similar to that associated with CDH observed in human
infants (5, 20-22, 26, 30). The weight, protein content, and DNA
content of lungs (31) were compared in CDH and control animals before
and after invasion of visceral organs into the thoracic cavity.
Immunohistochemical labeling for growth-associated protein (GAP-43) and
the polysialylated form of the neural cell adhesion molecule
(PSA-NCAM), both expressed within growing phrenic axons (3), was
performed to determine the pattern of phrenic axon intramuscular
branching from its onset at embryonic day
14.5 (E14.5) up
until near its completion at E18. In
conjunction with GAP-43 and PSA-NCAM immunolabeling, electron
microscopy of phrenic nerve cross sections provided information
regarding nerve diameter and axonal number before and after programmed
neuronal cell death in instances of CDH. Furthermore, we retrogradely
labeled phrenic motoneuron cell bodies with the lipophilic dye
1,1 METHODS Delivery of Nitrofen
-dioctadecyl-3,3,3,3-tetramethylindocarbocyanide perchlorate (DiI) to examine the distribution of
motoneurons in normal vs. CDH fetuses. Finally, the formation of the
primordial diaphragmatic anlage, the pleuroperitoneal fold, and the
onset of myotube formation within the diaphragm was examined via
immunolabeling for low-affinity nerve growth factor receptor (p75) and
PSA-NCAM. As shown in the present study, the primordial diaphragm
expresses the p75 receptor, whereas, as previously reported, developing diaphragmatic myotubes express PSA-NCAM (3).
In the present study, nitrofen was obtained from the United States Environmental Protection Agency and prepared as a solution of 100 mg/ml in olive oil. The timing of pregnancies was determined from the appearance of sperm plugs in the breeding cages (time designated as E0). Pregnant dams on the ninth day of gestation (E9) were temporarily (~10 min) anesthetized with halothane (1.25% in 95% O2-5% CO2) and given 100 mg of nitrofen via a gavage tube to produce either left, right, or bilateral hernias (Table 1). In two animals, nitrofen was administered on E11 to produce solely right-sided hernias.
|
|||||||||||||||||||||||||||||||
Cesarian Section and Tissue Preparation
Control and nitrofen-exposed fetal rats (E13.5-E18) were delivered by cesarean section from timed-pregnant Sprague-Dawley rats anesthetized with halothane (1.25% in 95% O2-5% CO2) and maintained at ~37°C by radiant heat. The ages of fetuses were confirmed by comparison of their crown-rump length measurements with those published by Angulo y Gonzalez (6). This measurement is important for confirming the precise age of individual fetuses. Embryos were decapitated, and, while they were immersed in 4% paraformaldehyde in a 0.2 M sodium phosphate buffer (pH 7.4), the thoracic and abdominal cavities were exposed. The tissue was then postfixed at 4°C for between 4 and 20 h.Whole Embryo Sections
After fixation, fetuses were washed in phosphate-buffered saline (PBS) and then placed for 1 hr in a 7.5% gelatin solution maintained at 30°C. They were then embedded in a 20% gelatin-glycerol solution that was hardened by cooling. A small block containing the fetus was excised and fixed overnight. The block was appropriately oriented for transverse sectioning and was then vibratome sectioned at 50 µm. Serial sections were washed in PBS, immunostained while free floating, and then mounted onto gelatin-coated slides, dried, coverslipped, examined, and photographed by standard light microscopy. Photographs were digitally scanned (ScanJet, Hewlett-Packard, Palo Alto, CA) into a computer, labeled by using CorelDraw software (Microsoft), and printed with a dye sublimation printer (Codonics NP600, Mitsubishi).Diaphragm Whole Mounts
Whole diaphragms were isolated immediately from fetal rats, pinned flat, and postfixed for 4-20 h. They were then washed in PBS, immunostained while free floating, and mounted on gelatin-coated slides.Immunolabeling
Antibodies. All primary antibodies used were diluted in PBS (pH 7.4) with 1% goat serum and 0.1% NaN3. We further added 0.4% Triton X-100 with the anti-p75 monoclonal antibody (MAb). Detection of GAP-43 was performed by using the mouse anti-GAP-43 immunoglobulin G (IgG) MAb (Sigma Chemical, St. Louis, MO) at a dilution of 1:500. PSA-NCAM was detected by using the mouse anti-PSA IgM MAb 12E3 (a generous gift from T. Seki, Juntendo University, Tokyo, Japan). 12E3-containing ascites fluid was diluted to 1:5,000-1:10,000. We detected p75 by using a mouse anti-p75 IgG MAb at a dilution of 1:75 (Boehringer Mannheim, Laval, Quebec). All secondary antibodies were diluted to 1:200 in PBS containing 1% goat serum. Secondary antibodies used for GAP-43, PSA-NCAM, and p75 receptor labeling were peroxidase-conjugated goat anti-mouse IgG (whole molecule; Sigma Chemical), biotinylated goat anti-mouse IgM (µ-chain specific; Sigma Chemical), and biotinylated goat anti-mouse IgG (whole molecule; Sigma Chemical), respectively. Immunohistochemistry. Tissues for all immunolabeling, except for anti-p75, were immersed in methanol containing 0.3% H2O2 for 20-45 min, followed by incubation in 1:20 goat serum (Sigma) in PBS for 1 h. For anti-p75 immunolabeling, the tissues were immersed in PBS containing 0.4% Triton X-100 and 0.3% H2O2, followed by 1:20 goat serum in PBS with 0.4% Triton X-100. After three 10-min PBS washes, all tissues were incubated in diluted primary antibody over 1-2 nights at 4°C. After three 30-min PBS washes, tissues were incubated in the appropriate secondary antibody for 1-2 h at room temperature. Tissues treated with 12E3 and anti-p75 MAb were further incubated in a 1% avidin-biotinylated-peroxidase complex (ABC; kit PK-4000, Vectastain) for 1-2 h. Antibody labeling was then revealed by a 3,3-diaminobenzidine tetrahydrochloride (DAB) product intensified with nickel ions [0.1 M tris(hydroxymethyl)aminomethane (Tris)-buffered solution (pH 8) containing 0.04% DAB with 0.04% H2O2 and 0.6% nickel ammonium sulphate] for 5-15 min at room temperature. This produced an intense purple-black precipitate. After being washed thoroughly, tissues were mounted and examined as above. Controls were provided by primary antibody omission or by use of an inappropriate secondary antibody. DiI labeling of phrenic motoneurons. Fetal rats at age E18 were removed as described above and immediately placed in 4% paraformaldehyde; the head and abdomen were removed. Tissue covering the neuraxis and thorax was opened to allow rapid fixation. The tissue was then dissected to isolate the cervical neuraxis and the phrenic and brachial nerves. After the tissue was left in fixative on a shaker at 4°C for 2-4 days, the phrenic nerve was cut at the level of the thymus. The distal end of the nerve was stripped of connective tissue and cuffed in a small crystal of fast DiI (Molecular Probes). The distal nerve and DiI crystal were sealed in a strip of Parafilm to prevent DiI diffusion into other tissues. Tissues were placed in 1.2% paraformaldehyde, pH 9.5, for 2 mo at 35°C to allow time for complete neuronal labeling. The tissue was removed, and the cervical spinal cord, with lower brain stem, dorsal root ganglia, and ventral roots, was isolated. Tissues were placed in 4% paraformaldehyde on a shaker at 4°C for up to 7 days. They were then washed in PBS and embedded in 3.5% agar. A block containing the tissue was excised and fixed in 4% paraformaldehyde on a shaker at 4°C for up to 3 days. Vibratome serial sections of 70 µm in the horizontal plane were collected and washed in PBS containing 0.1% NaN3 at pH 7.4. Sections were mounted onto microscope slides coated with gelatin and coverslipped to keep the sections moist. Slides were stored at 4°C in a humid chamber. Photographs of labeled neurons were taken by using a camera attached to a Leitz Diaplan epifluorescent microscope.Electron Microscopy of Phrenic Axons
Axons from control and nitrofen-exposed rats were examined in phrenic nerve sections taken ~500 µm rostral to the point of innervation of the diaphragm. Nerves were immersed in a mixture of 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 2-4 h. After three washes of 5 min each in 0.1 M cacodylate (pH 7.4), the nerves were postfixed for 15 min in a mixture of 1% OsO4 and 0.1 M phosphate buffer (pH 7.4). The tissue was then washed three times in distilled water, dehydrated in graded ethanol, and embedded in resin. Sections were cut with a microtome, stained with uranyl acetate and lead citrate, and observed with a Philips 410 electron microscope. Photomicrographs (×4,300) were taken, and measurements of nerve area were made by using an image-analysis system (Java; Jandel). Axon numbers were counted by viewing the photograph negatives with a stereo microscope at ×10 magnification.Measurements of Lung Weight, Protein, and DNA Content
Preparation of the lungs. Lungs were removed, weighed, quickly frozen in liquid nitrogen, and stored at
80°C until analyzed, when they were defrosted and
kept on ice. Each lung was homogenized in 1 ml distilled water in an
ice bath with a polytron homogenizer at setting number 5 for 30 s
(Brinkman Instruments, Westbury, NY). The homogenate was divided into
two 500-ml aliquots for measuring protein and DNA content.
Protein assay.
Protein was determined by using an array spectrophotometer (model
8452A, Hewlett-Packard) with a Bradford microassay (Bio-Rad Laboratories, Hercules, CA; see Ref. 6). Bovine serum albumin (Sigma
Chemical) was used for the standard.
DNA assay.
The DNA quantitation technique was adapted from Downs and Wilfinger
(11). Homogenate and DNA extraction solution (1 M
NH4OH, 10 mM EDTA) were incubated
at 37°C in a shaking water bath for 30 min. After centrifugation at
2,500 revolutions/min for 3 min, 25 µl of supernatant was added to 35 µl of distilled water and further centrifuged in an evaporator
centrifuge for 10 min. Distilled water was added to make a final volume
of 500 µl. Then, 50 µl were removed and added to 1.5 ml dye
solution, prepared by mixing 50 µl Hoechst 33538 and 100 ml DNA assay
buffer (in mM: 100 NaCl, 10 EDTA, 10 Tris, pH 7.0). Samples to be
measured were then vortexed and left at room temperature for 30 min
before DNA concentration was determined by using a fluorescence
spectrophotometer (Hitachi F-2000). Graded known concentrations of calf
thymus DNA (Sigma Chemical) were used as a reference.
All protocols described above were approved by the Animal Welfare
Committee at the University of Alberta. Results are expressed as means ± SE, and any differences were tested by using an unpaired Student's t-test. Significance was
accepted at P values < 0.05.
RESULTS
Hernias Induced by Nitrofen
Administration of a single dose of nitrofen on E9 caused right, left, and bilateral hernias (Table 1). Administration of nitrofen on E11 resulted in the formation of right-sided hernias only. The range of sizes and locations of diaphragm malformations are illustrated in Fig. 1. The range of defects included mild to very severe left-sided malformations with ~25-90% of the muscle missing, mild to medium right-sided malformations with 10-50% of the muscle missing, and bilateral malformations. All malformations included the posterolateral area referred to as the region of Bochdalek (27).
Lung Growth
Measurements of lung growth were made to determine whether the lung hypoplasia associated with CDH occurred pre- or postinvasion of the abdominal contents into the thoracic space (E15 or E18, respectively). For the lung measurements, only medium to severe defects were used. With these diaphragmatic malformations at E18, there was significant invasion of the thoracic cavity by abdominal contents. At E15, however, the abdominal contents had not grown sufficiently to herniate into the thoracic cavity. Body weight, lung weight, lung protein, and DNA content were measured in control and CDH rats at ages E15 and E18.As illustrated in Table 2, there were no significant differences in the body weight, lung weight, lung protein, and lung DNA content between controls and animals with extensive diaphragmatic malformations at age E15. At age E18, there was a significant reduction in overall lung weight, as well as protein and DNA contents of the lungs, in herniated animals compared with control, all suggesting a decreased cell content within the lung. Thus, collectively, these data illustrate that lung hypoplasia is a secondary effect, resulting from the restricted thoracic space associated with the misplacement of abdominal contents, rather than a primary defect that precedes diaphragm malformation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phrenic Nerve
These measurements were made to assay whether or not the phrenic nerve was malformed with CDH and, if so, to determine whether or not phrenic nerve atrophy occurred before or secondarily to the diaphragmatic malformations. To quantify the diameter of phrenic nerves in normal and herniated animals, transmission electron micrographs of nerve cross sections were examined. Figure 2 shows the left and right nerves from three animals, one at age E15 (left defect) and two at age E18 (left and right defects). There was no significant difference in the areas of the nerve ipsilateral (589 ± 31 µm2; n = 3) and contralateral (550 ± 41 µm2; n = 3) to the diaphragmatic defect at E15. However, at E18, the phrenic nerve ipsilateral to the abnormality had atrophied. Measurements of nerve area confirmed that the nerve ipsilateral to the diaphragmatic defect was significantly smaller (814 ± 6 µm2; n = 6) than the contralateral nerve (1,348 ± 8 µm2; n = 9). Counts of axon numbers in phrenic nerves from two fetal rats at age E18 with large left-sided diaphragmatic defects demonstrated that the reduced nerve area resulted from a decrease in the total number of axons: 582 and 695 axons in the ipsilateral vs. 1,078 and 1,061 axons in the contralateral phrenic nerves were counted in the two animals, respectively. These observations can be explained by the fact that the majority of phrenic motoneuron cell death occurs between E15 and E16. Thus the degree of motoneuron survival within the ipsilateral motoneuron pool would be compromised by the reduced musculature and its associated target-derived neurotrophic factors (16).
The decrease in the normal number of phrenic motoneurons ipsilateral to the hernia after naturally occurring cell death was also evident from retrograde fills with DiI at age E18 (Fig. 3). The number of motoneurons counted within the phrenic motoneuron pool ipsilateral to large left-sided hernias was 67 ± 8% of the contralateral side (n = 6; P < 0.05). Note that there is normally a well-defined topographical innervation of the diaphragm, with the dorsal regions of the musculature innervated primarily by phrenic motoneurons within the C5-C6 cervical segments of the motoneuron pool (23). The sternal region is primarily innervated by motoneurons located at the level of the third and fourth cervical segments. Thus, without a compensatory mechanism whereby phrenic axons reestablish an essentially normal topographic projection within the remaining musculature, one would expect a massive die off of neurons caudal to C4 regions. Clearly, this is not the case, as decreased access of phrenic axons to the normal amount of musculature results in a loss of survival that, while slightly heavier within caudal regions, is shared by the remainder of the phrenic motoneuron column. The phrenic nerve appears capable of compensation, in that, although translocated ventrally, the characteristic trifurcation at the primary branching site is retained (Fig. 4A). Furthermore, axons were often observed projecting around the herniated region, being diverted laterally or medially in search of their normal but displaced target (Figs. 1, 4, and 5, B and C).
-Dioctadecyl-3,3,3,3-tetramethylindocarbocyanide
perchlorate (DiI) retrograde fills of phrenic motoneurons at
E18 demonstrate that fewer motoneurons
survive within phrenic motoneuron pool on side ipsilateral to
diaphragmatic malformation. A-D:
ventrodorsal progression of motoneuron distribution within phrenic
motor pool at cervical segments, levels
C3-C6, respectively. Sections were cut at
70 µm. Note that fewer motoneurons are labeled throughout rostrocaudal distribution of phrenic motor pool on side ipsilateral (left) to hernia (3/4 of diaphragm
was missing from left) compared with
contralateral (right) side. Scale
bar, 200 µm.
Myotube Formation
To determine whether myotube formation was abnormal in the region of the herniation, we labeled for PSA-NCAM, a molecule that is expressed on the membranes of myotubes during myogenesis (3). Examples are shown of whole diaphragms taken from two animals at age E17, one with a large left diaphragmatic defect labeled for PSA-NCAM (Fig. 4A) and the other with a medium-sized defect labeled for GAP-43 (Fig. 4B). Cross sections, taken from diaphragms identical to those presented as whole mounts and immunolabeled for PSA-NCAM, show that the density of labeling, reflecting myotube number, was highest in regions adjacent to the hernia. Thus, myotube formation within the herniated diaphragms is only abnormal in that myotubes normally destined to span the region of herniation have accumulated adjacent to it. We did not, however, count the number of myotubes in control vs. CDH diaphragms. Thus, the possibility of the formation of fewer myotubes has not been addressed. Close examination of PSA-NCAM labeling demonstrates that the usual mediolateral extension of myotubes is often displaced as a result of the diaphragmatic malformation, with myotubes often extending more ventrodorsally around the lateral edge of the defective area (as in Fig. 1, B and E). The extension of myotubes along the lateral extent of the more severe defects (as in Fig. 1B) likely induced the often-observed abnormal projection of axons.Closure of the Pleuroperitoneal Canal
We exposed pregnant rats to nitrofen at E9 and examined the fetal diaphragms for defects at E14.5, before pleuroperitoneal canal closure. Our rationale was that if the hernia occurred as a result of the failure of pleuroperitoneal canal closure, then no defects would be observed before E15. The left and right pleuroperitoneal canals in fetal rats typically close at ages E14.75 and E15.25, respectively (12). The location of the pleuroperitoneal canals in a normal diaphragm from an animal aged E14.5 is illustrated in Fig. 5A. Two diaphragms from animals aged E14.5 that have been exposed to nitrofen on E9 are shown beside the control diaphragm (Fig. 5, B and C). There are clear defects that appear before canal closure on both left (Fig. 5, B and C) and right sides (Fig. 5C). Furthermore, the region of diaphragmatic malformation clearly occurs medially of the canal. Thus the abnormality must occur independently from a simple failure of pleuroperitoneal canal closure.Formation of the Primordial Diaphragm: the Pleuroperitoneal Fold
The primordial diaphragmatic muscle tissue is located within the pleuroperitoneal fold. This fold of tissue in a control animal is demonstrated in Fig. 6B. We knew from earlier observations that a track of cells, preceding phrenic nerve outgrowth and cells within the pleuroperitoneal fold, expressed NCAM and the low-affinity nerve growth factor (p75) receptor (2). The cells expressing these two molecules are likely Schwann and/or muscle cell precursors (29). Regardless, we took advantage of the characteristic immunolabeling for p75 receptors in control and nitrofen-exposed animals aged E13.5 to determine whether the pleuroperitoneal fold was malformed in the instance of CDH. We observed defects of the left and right pleuroperitoneal fold among nitrofen-exposed animals. Figure 6A shows a large defect within the left pleuroperitoneal fold of one such fetus at age E13.5. More rostral sections demonstrate that the nerve reached the displaced pleuroperitoneal fold by its projection through the pleuropericardial membrane (as in normal fetuses), which is fused with the diminished pleuroperitoneal fold.
DISCUSSION
This systematic study evaluated the status of the lung, the phrenic nerve, and diaphragmatic muscle formation at various stages during the course of the abnormal development of the diaphragm associated with nitrofen-induced CDH. We demonstrated that previously proposed theories regarding the primary role of the lung, phrenic nerve, myotube formation, and the closure of pleuroperitoneal canal in the pathogenesis of CDH are incorrect. Rather, the primary defect associated with CDH occurs, at an early stage, with the formation of the primordial diaphragm within the pleuroperitoneal fold.
General Comments on the Nitrofen Model for CDH
Nitrofen is a diphenyl ether herbicide that acts by an unknown mechanism to control broad-leaved weeds. Initial toxicological studies revealed that, whereas nitrofen was relatively nontoxic to adult animals, it did produce a number of lethal abnormalities associated with pulmonary and cardiovascular malfunction in fetuses exposed prenatally (5, 9, 13, 24). When given as a single dose on gestation day E9 or E11, the major abnormality produced by nitrofen was the maldevelopment of the diaphragm. As illustrated in Fig. 1, the range and location of hernias produced by nitrofen in the rat are remarkably similar to that observed in the human congenital anomaly. In the rat CDH model, the extent of the invasion of abdominal contents into the thoracic cavity varied according to the size of the defect within the diaphragmatic musculature. In humans, the extent of herniation also varies and is a critical determinant of the subsequent degree for pulmonary hypoplasia and the eventual prognosis (1). Furthermore, it is interesting to note that the rate of fetal reabsorptions increases in rats after administration of nitrofen at gestational age E9. In this context, it has been estimated that ~1:1,000-2,000 human fetuses do not survive to term because of complications associated with CDH and accompanying defects (15). Although there is no concrete data associating environmental toxins with the etiology of CDH, there does seem to be a remarkable similarity between the nitrofen model and the majority of human CDH anomalies. However, differences between the rat nitrofen model and the human condition include the fact that multiple congenital anomalies are associated with CDH in ~30% of infants (10, 25). Typically, associated anomalies (e.g., cardiac malformations, hydrocephalus, skeletal malformations) occur in the rat model only when the dam has been chronically exposed to high levels of nitrofen. Furthermore, ~10% of the cases in which CDH is associated with multiple congenital anomalies in infants can be linked to specific genetic abnormalities (i.e., trisomy 13 and 18 as well as Fryn's syndrome; see Refs. 10, 25).Lung Development
Previous reports have suggested that the lung is malformed independently, and perhaps as a cause, of the diaphragmatic anomalies. Two sources for this thinking have persisted in the literature. First, Iritani (18) showed a photograph of an abnormal lung and adjacent tissue that was referred to as the posthepatic mesenchymal plate (PHMP). In that experimental paradigm, nitrofen was fed ad libitum to pregnant rats from E5 to E11, and a number of developmental anomalies arose as a result. It may have been that massive doses of nitrofen administered at very early stages for long periods disrupted a number of tissues, including the lungs. However, Kluth et al. (22) reexamined the issue of whether the lung was atrophied at an early stage (E14) of diaphragmatic malformation in rats. They concluded, also, from visual inspection with scanning electron microscopy, that the lungs were normal before the invasion of the abdominal contents into the thoracic cavity. The quantitative analysis of lung size and cell content in the present study demonstrates that lung hypoplasia is indeed a secondary effect rather than a primary cause of the diaphragm malformation. The second line of evidence that has been presented implicating the lung as a source of the anomaly has been the fact that the lung contralateral to the herniation is sometimes hypoplastic in newborns with CDH. However, the contralateral hypoplasia, which is often minor compared with the ipsilateral defect, can be explained by the fact that the mediastinum, and subsequently the contralateral lung, is compressed by the presence of the invading viscera. Thus, considering the evidence presented when nitrofen is administered in a manner to minimize associated anomalies, lung development is normal at the early stages of CDH progression and is only compromised as a secondary result of the subsequent migration of viscera through the diaphragmatic opening.Status of the Phrenic Nerve
The phrenic nerve innervating the herniated side of a diaphragm in older fetal rats (after E16) often appears smaller in diameter compared with that of the unaffected side. The electron micrographs of the phrenic nerve (Fig. 2) and the retrograde fills of phrenic motoneurons (Fig. 3) in the present study provide quantitative evidence for this observation. However, these abnormalities are also a result of, rather than a cause of, CDH. Before naturally occurring neuronal cell death (E15; see Ref. 16), the numbers of phrenic motoneurons and axons in CDH fetuses were similar to those in control animals on both ipsi- and contralateral sides to the herniation. This apparent discrepancy can be explained by the fact that the number of neuronal cell bodies and axons that remain after the period of apoptosis is critically determined by the target tissue (14). In severely herniated diaphragms, a significant proportion of the target is missing, and the remaining musculature is arranged abnormally, thereby explaining the increased phrenic motoneuron cell death.Diaphragm Formation
The notion that myotubes in the region of the herniation form in a weak fashion and then rupture due to the pressure induced by the underlying viscera does not hold up with the nitrofen model. Rather, it is clear that myotube formation is enhanced adjacent to the hernia, with some of the myotubes normally destined for the herniated region aligning next to the diaphragmatic opening.Similarly, our data do not support the idea that the herniation results from a failure of pleuroperitoneal canal closure. First, herniation often occurs medial to the pleuroperitoneal canals. Secondly, it was obvious that well-defined holes in the diaphragm were present on either the right or left side at E14.5, ~0.25 and 0.75 days before the closure of the right and left pleuroperitoneal canals, respectively (12). Kluth et al. (22) also noted malformations on the right side of diaphragms at E14 in response to nitrofen administration at E11, which is consistent with the defects in the diaphragm occurring before closure of the pleuroperitoneal canal.
The malformation of the diaphragmatic musculature clearly occurs at a stage of development earlier than myotube formation and pleuroperitoneal canal closure. In the present study, the primordial diaphragmatic tissue, the pleuroperitoneal fold, was found to be grossly malformed in the nitrofen model of CDH. As a result, the nerve migrates past its normal point of innervation, which is missing in left hernias, and innervates tissue ventrally. It is interesting that the phrenic nerve branches in a pattern similar to normal development, even when its primordial target is either missing or misplaced in the instances of CDH. It would be interesting to study potential topographically organized cues in normal and herniated diaphragms to better understand this adjustment phenomenon. After E13.5, herniated diaphragms then develop without the normal substrate for the medial and dorsal regions.
The tissue classified by Iritani (18) as the PHMP is likely a portion of the pleuroperitoneal fold. As far as we have been able to discern, there has not been a single anatomical description of a tissue analogous to the PHMP described independently from that proposed by Iritani (18). Moreover, others have raised doubts regarding the identity of the PHMP, suggesting that it is a part of the dorsal mesenchyme of the septum transversum. With the clearer visualization of the tissue with the presently available immunohistochemical markers, it is obvious that the phrenic nerve enters the pleuroperitoneal fold, which is fused at its ventral extent with the septum transversum (2).
The present data clearly show that the diaphragmatic defect associated with maternal nitrofen exposure occurs with the initial rather than the latter stages of diaphragm development. It will now be important to determine whether it is a matter of improper muscle precursor cell migration from somites or a malformation of the mesenchymal tissue that provides the supporting structure for diaphragm formation. The fact that left-sided hernias only occur when nitrofen is administered at E9 suggests that the primary insult must occur during a well-defined time frame. A past study (8) of the distribution and metabolism of orally administered nitrofen in rats has shown that nitrofen reaches the fetus within 2 h after administration, with the level peaking at 4-6 h and declining to half the initial value by 24 h. One proposal regarding the pathogenesis of CDH suggests that there is an increased amount of cell death in the cervical somites associated with nitrofen administration (4). However, the correlation was not quite so clear, as the increased cell death was bilateral in instances of presumptive left-sided herniation and totally absent in instances of presumptive right-sided herniation. A further complication arose in that study, because it was assumed that all herniations would be left-sided in response to nitrofen administration at E9, which has been illustrated in this and past studies (21) to be an overgeneralization. Clearly, further studies regarding the source of diaphragmatic premuscle tissue in the normal and pathological states are needed to address this issue. We are now focusing on two potential features of pleuroperitoneal fold development that may be affected during CDH development: the migration of muscle precursors from somites and the deposition of the mesenchymal substructure on which the diaphragmatic musculature forms.
ACKNOWLEDGEMENTS
The authors thank H. Chan and M. Schoenmakers for technical assistance and Dr. K. Bagnall for valuable comments.
FOOTNOTES
Address for reprint requests: J. J. Greer, Div. of Neuroscience, 513 HMRC, Univ. of Alberta, Edmonton, Alberta, Canada, T6G 2S2 (E-mail: JGREER{at}physio.med.ualberta.ca).
Received 30 October 1996; accepted in final form 21 March 1997.
REFERENCES
| 1. | Adzick, H. S., M. R. Harrison, P. L. Glick, D. K. Nakayama, F. A. Manning, and A. A. deLorimier. Diaphragmatic hernia in the fetus: prenatal diagnosis and outcome in 94 cases. J. Pediatr. Surg. 20: 357-361, 1985[Medline]. |
| 2. | Allan, D. W., and J. J. Greer. Embryogenesis of the phrenic nerve and diaphragm in the fetal rat. J. Comp. Neurol. 382:459-468. |
| 3. | Allan, D. W., and J. J. Greer. Spatiotemporal expression of polysialated NCAM during phrenic nerve outgrowth and intradiaphragmatic branching (Abstract). Soc. Neurosci. Abstr. 25: 740.8, 1995. |
| 4. | Alles, A. J., P. D. Losty, P. K. Donahoe, T. F. Manganaro, and J. J. Schnitzer. Embryonic cell death patterns associated with nitrofen-induced congenital diaphragmatic hernia. J. Pediatr. Surg. 30: 353-360, 1995[Medline]. |
| 5. | Ambrose, A. M., P. S. Larson, J. F. Borzellieca, R. Blackwell-Smith, and G. R. Hennigar. Toxicologic studies on 2,4-dichlorophenyl-p-nitrophenyl ether. Toxicol. Appl. Pharmacol. 19: 263-275, 1971[Medline]. |
| 6. | Angulo y Gonzalez, A. W. The prenatal growth of the albino rat. Anat. Rec. 52: 117-138, 1932. |
| 7. | Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976[Medline]. |
| 8. | Costlow, R. D., and J. M. Manson. Distribution and metabolism of the teratogen nitrofen (2,4-dichloro-4-nitro diphenyl ether) in pregnant rats. Toxicology 26: 11-23, 1983[Medline]. |
| 9. | Costlow, R. D., and J. M. Manson. The heart and diaphragm: target organs in the neonatal death induced by nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether). Toxicology 20: 209-227, 1981[Medline]. |
| 10. | Dillon, E., and M. Renwick. Antenatal detection of congenital diaphragmatic hernias: the northern region exposure. Clin. Radiol. 48: 264-267, 1993[Medline]. |
| 11. | Downs, T. R., and W. W. Wilfinger. Fluorometric quantification of DNA in cells and tissue. Ann. Biochem. Exp. Med. (Calcutta) 131: 538-548, 1983. |
| 12. | Gattone, V. H., and D. E. Morse. Pleuroperitoneal canal closure in the rat. Anat. Rec. 208: 445-460, 1984[Medline]. |
| 13. | Gray, L. E., R. J. Kavlock, N. Chernoff, J. Ostby, and J. Ferrell. Postnatal developmental alterations following prenatal exposure to the herbicide 2,4-dichlorophenyl-p-nitrophenyl ether: a dose response evaluation in the mouse. Teratol. Appl. Pharmacol. 67: 1-14, 1983. |
| 14. | Hamburger, V. Cell death in the development of the lateral motor column of the chick embryo. J. Comp. Neurol. 160: 535-546, 1975[Medline]. |
| 15. | Harding, R. Development of the respiratory system. In: Textbook of Fetal Physiology, edited by G. D. Thorburn, and R. Harding. New York: Oxford Univ. Press, 1994, p. 140-167. |
| 16. | Harris, A. J., and C. D. McCaig. Motoneuron death and motor size during embryonic development of the rat. J. Neurosci. 4: 13-24, 1984[Abstract]. |
| 17. | Harrison, M. R., N. S. Adzick, J. M. Estes, and L. J. Howell. A prospective study of the outcome for fetuses with diaphragmatic hernia. J. Am. Med. Assoc. 271: 382-384, 1994[Abstract]. |
| 18. | Iritani, I. Experimental study on embryogenesis of congenital diaphragmatic hernia. Anat. Embryol. 169: 133-139, 1984[Medline]. |
| 19. | Karamanoukian, H. L., P. L. Glick, D. T. Wilcox, J. E. Rossman, B. A. Hom, and F. C. Morin. Pathophysiology of congenital diaphragmatic hernia. VIII: Inhaled nitric oxide requires exogenous surfactant therapy in the lamb model of congenital diaphragmatic hernia. J. Pediatr. Surg. 30: 1-4, 1995[Medline]. |
| 20. | Kluth, D., C. Petersen, and H. J. Zimmermann. The embryology of congenital diaphragmatic hernia. In: Congenital Diaphragmatic Hernia, edited by P. Puri. Basel, Switzerland: Karger, 1989, vol. 24, p. 7-21. (Modern Problems in Paediatrics Ser.) |
| 21. | Kluth, D., R. Kangah, P. Reich, R. Tenbrinck, D. Tibboel, and W. N. Lambrecht. Nitrofen-induced diaphragmatic hernias in rats: an animal model. J. Pediatr. Surg. 25: 850-854, 1990[Medline]. |
| 22. | Kluth, D., R. Tenbrinck, M. Ekesparre, R. Kangah, P. Reich, A. Brandsma, D. Tibboel, and W. Lambrecht. The natural history of congenital diaphragmatic and pulmonary hypoplasia in the embryo. J. Pediatr. Surg. 28: 456-463, 1993[Medline]. |
| 23. | Laskowski, M. B., and J. R. Sanes. Topographic mapping of motor pools onto skeletal muscles. J. Neurosci. 7: 252-260, 1987[Abstract]. |
| 24. | Ostby, J. S., L. E. Gray, R. J. Kavlock, and J. M. Ferrell. The postnatal effects of prenatal exposure to low doses of nitrofen (2,4, dichlorophenyl-p-nitrophenyl ether) in Sprague-Dawley rats. Toxicology 34: 285-297, 1985[Medline]. |
| 25. | Philip, N., D. Gambarelli, J. M. Guys, J. Camboulives, and S. Ayme. Epidemiological study of congenital diaphragmatic defects with special reference to aetiology. Eur. J. Pediatr. 150: 726-729, 1991[Medline]. |
| 26. | Puri, P. Epidemiology of congenital diaphragmatic hernia. In: Congenital Diaphragmatic Hernia, edited by P. Puri. Basel, Switzerland: Karger, 1989, vol. 24, p. 22-28. (Modern Problems in Paediatrics Ser.) |
| 27. | Skandalakis, J. E., S. W. Gray, and R. R. Ricketts. The diaphragm. In: Embryology for Surgeons, edited by J. E. Skandalakis and S. W. Gray. Baltimore, MD: Williams & Wilkins, chapt. 15, p. 491-539, 1994. |
| 28. | Torfs, C. P., C. J. Curry, T. F. Bateson, and L. H. Honore. A population-based study of congenital diaphragmatic hernia. Teratology 46: 555-565, 1992[Medline]. |
| 29. | Wheeler, E. F., and M. Bothwell. Spatiotemporal patterns of NGF and the low-affinity NGF receptor in rat embryos suggest functional roles in tissue morphogenesis and myogenesis. J. Neurosci. 12: 930-945, 1992[Abstract]. |
| 30. | Wickman, D. S., J. R. Siebert, and D. R. Benjamin. Nitrofen-induced congenital diaphragmatic defects in CD1 mice. Teratology 47: 119-125, 1993[Medline]. |
| 31. | Zamenhof, S., H. Bursztyn, K. Rich, and P. J. Zamenhof. The determination of deoxyribonucleic acid and of cell number in brain. J. Neurochem. 11: 505-509, 1964[Medline]. |
This article has been cited by other articles:
|
|
 |
|
  R. D. Clugston, W. Zhang, and J. J. Greer Gene expression in the developing diaphragm: significance for congenital diaphragmatic hernia Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L665 - L675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Clugston, J. Klattig, C. Englert, M. Clagett-Dame, J. Martinovic, A. Benachi, and J. J. Greer Teratogen-Induced, Dietary and Genetic Models of Congenital Diaphragmatic Hernia Share a Common Mechanism of Pathogenesis Am. J. Pathol., November 1, 2006; 169(5): 1541 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Folkesson, C. J. Chapin, L. L. Beard, R. Ertsey, M. A. Matthay, and J. A. Kitterman Congenital diaphragmatic hernia prevents absorption of distal air space fluid in late-gestation rat fetuses Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L478 - L484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Babiuk, B. Thebaud, and J. J. Greer Reductions in the incidence of nitrofen-induced diaphragmatic hernia by vitamin A and retinoic acid Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L970 - L973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mey, R. P. Babiuk, R. Clugston, W. Zhang, and J. J. Greer Retinal Dehydrogenase-2 Is Inhibited by Compounds that Induce Congenital Diaphragmatic Hernias in Rodents Am. J. Pathol., February 1, 2003; 162(2): 673 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Babiuk and J. J. Greer Diaphragm defects occur in a CDH hernia model independently of myogenesis and lung formation Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1310 - L1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Greer, D. Cote, D. W. Allan, W. Zhang, R. P. Babiuk, L. Ly, R. P. Lemke, and K. Bagnall Structure of the primordial diaphragm and defects associated with nitrofen-induced CDH J Appl Physiol, December 1, 2000; 89(6): 2123 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Guilbert, S. A. Gebb, and J. M. Shannon Lung hypoplasia in the nitrofen model of congenital diaphragmatic hernia occurs early in development Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1159 - L1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Keijzer, J. Liu, J. Deimling, D. Tibboel, and M. Post Dual-Hit Hypothesis Explains Pulmonary Hypoplasia in the Nitrofen Model of Congenital Diaphragmatic Hernia Am. J. Pathol., April 1, 2000; 156(4): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kitano, P. Davies, D. von Allmen, N. S. Adzick, and A. W. Flake Fetal tracheal occlusion in the rat model of nitrofen-induced congenital diaphragmatic hernia J Appl Physiol, August 1, 1999; 87(2): 769 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Thebaud, D. Tibboel, C. Rambaud, J.-C. Mercier, J. R. Bourbon, A. T. Dinh-Xuan, and S. L. Archer Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L423 - L429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Greer, D. W. Allan, M. Martin-Caraballo, and R. P. Lemke An overview of phrenic nerve and diaphragm muscle development in the perinatal rat J Appl Physiol, March 1, 1999; 86(3): 779 - 786. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
